GLP-1 RAs are one of the ever-increasing number of important drug classes used in the management of type 2 diabetes and are playing an increasing role within primary care. But when and in whom can they be used? And what impact do they have on disease progression and long-term complications?

This face-to-face meeting aims to provide you with practical information on how to optimise the use of GLP-1 RAs, in particular Ozempic^® (semaglutide). You will have the opportunity to:

• attend a series of hands-on, small-group workshops of your choice
• hear from an engaging faculty of local speakers
• participate in interactive case-based learning
• have your own questions answered.

Don’t miss this unique opportunity to attend a highly practical gold-standard educational event!